A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(9 sites)

Honduras

Investigational Site Number : 3400001, San Pedro Sula

Investigational Site Number : 3400002, Tegucigalpa

Investigational Site Number : 3400003, Tegucigalpa

Investigational Site Number : 3400007, Tegucigalpa

Mexico

Investigational Site Number : 4840007, Torreón, Coahuila

Investigational Site Number : 4840013, Cuernavaca, Morelos

Investigational Site Number : 4840015, Tizimín, Yucatán

Investigational Site Number : 4840009, Chihuahua City

Investigational Site Number : 4840005, Ecatepec de Morelos